4-122922467-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_007083.5(NUDT6):āc.106G>Cā(p.Val36Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000875 in 1,612,028 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_007083.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUDT6 | NM_007083.5 | c.106G>C | p.Val36Leu | missense_variant | 1/5 | ENST00000304430.10 | NP_009014.2 | |
NUDT6 | NM_198041.3 | c.-270+334G>C | intron_variant | NP_932158.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUDT6 | ENST00000304430.10 | c.106G>C | p.Val36Leu | missense_variant | 1/5 | 1 | NM_007083.5 | ENSP00000306070 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000228 AC: 55AN: 241636Hom.: 1 AF XY: 0.000257 AC XY: 34AN XY: 132308
GnomAD4 exome AF: 0.0000843 AC: 123AN: 1459720Hom.: 2 Cov.: 29 AF XY: 0.000114 AC XY: 83AN XY: 726260
GnomAD4 genome AF: 0.000118 AC: 18AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2024 | The c.106G>C (p.V36L) alteration is located in exon 1 (coding exon 1) of the NUDT6 gene. This alteration results from a G to C substitution at nucleotide position 106, causing the valine (V) at amino acid position 36 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at